000 01324 a2200361 4500
005 20250516162016.0
264 0 _c20140430
008 201404s 0 0 eng d
022 _a1865-8652
024 7 _a10.1007/s12325-013-0044-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMadsen, Bjørn S
245 0 0 _aTargeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.
_h[electronic resource]
260 _bAdvances in therapy
_cJul 2013
300 _a659-70 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aBacterial Translocation
650 0 4 _aCarcinoma, Hepatocellular
_xetiology
650 0 4 _aHepatic Encephalopathy
_xetiology
650 0 4 _aHepatorenal Syndrome
_xetiology
650 0 4 _aHumans
650 0 4 _aHypertension, Portal
_xcomplications
650 0 4 _aLiver Cirrhosis
_xcomplications
650 0 4 _aLiver Neoplasms
_xetiology
650 0 4 _aMicrobiota
650 0 4 _aPeritonitis
_xetiology
700 1 _aHavelund, Troels
700 1 _aKrag, Aleksander
773 0 _tAdvances in therapy
_gvol. 30
_gno. 7
_gp. 659-70
856 4 0 _uhttps://doi.org/10.1007/s12325-013-0044-1
_zAvailable from publisher's website
999 _c22943404
_d22943404